Prostate MRI technical parameters standardization: a systematic review on adherence to PI-RADSv2 acquisition protocol

R Cuocolo, A Stanzione, A Ponsiglione, F Verde… - European Journal of …, 2019 - Elsevier
Abstract Purpose The Prostate Imaging-Reporting and Data System has been developed to
standardize prostate MRI in terms of acquisition, interpretation and reporting. It received a …

Comparison of biparametric and multiparametric mri for clinically significant prostate cancer detection with PI‐RADS version 2.1

T Tamada, A Kido, A Yamamoto… - Journal of Magnetic …, 2021 - Wiley Online Library
Background Biparametric MRI (bpMRI) without dynamic contrast‐enhanced MRI (DCE‐MRI)
results in an elimination of adverse events, shortened examination time, and reduced costs …

Round table: arguments in supporting abbreviated or biparametric MRI of the prostate protocol

M Scialpi, E Martorana, P Scialpi, A D'Andrea… - Abdominal …, 2020 - Springer
Abstract Prostate Imaging Reporting and Data System (PI-RADS) version 2.1 update, in the
attempt to improve clinical guidelines for multiparametric magnetic resonance imaging …

Prebiopsy biparametric MRI for clinically significant prostate cancer detection with PI-RADS version 2: a multicenter study

MH Choi, CK Kim, YJ Lee… - American Journal of …, 2019 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to evaluate the diagnostic performance of the
Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) with respect to …

A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions

Y Hou, ML Bao, CJ Wu, J Zhang, YD Zhang… - Abdominal Radiology, 2020 - Springer
Purpose PI-RADS score 3 is recognized as equivocal likelihood of clinically significant
prostate cancer (csPCa) occurrence. We aimed to develop a Radiomics machine learning …

PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?

L Rico, L Blas, G Vitagliano, P Contreras… - … Oncology: Seminars and …, 2021 - Elsevier
Introduction Currently, a new subclassification of the Pi-RADS 3 lesions and subgroups is
being used: 3a (indolent or low-risk lesions with volume< 0.5 ml) and 3b (significant or high …

Evolution of prostate MRI: from multiparametric standard to less-is-better and different-is better strategies

R Girometti, L Cereser, F Bonato, C Zuiani - European radiology …, 2019 - Springer
Multiparametric magnetic resonance imaging (mpMRI) has become the standard of care to
achieve accurate and reproducible diagnosis of prostate cancer. However, mpMRI is quite …

The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI

J Song, C Zhao, F Zhang, Y Yuan, LM Wang, V Sah… - Abdominal …, 2023 - Springer
Objectives To compare the diagnostic performance for the detection of clinically significant
prostate cancer (csPCa) between bpMRI with only axial T2WI (simplified bpMRI) and …

[HTML][HTML] Lesion Volume in a Bi-or Multivariate Prediction Model for the Management of PI-RADS v2. 1 Score 3 Category Lesions

E Martorana, MC Aisa, R Grisanti, N Santini… - Turkish Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: This study aimed at improving the discrimination of Prostate Imaging–Reporting
and Data System version 2.1 (PI-RADS v2. 1) score 3 suspicious prostate cancer lesions …

Regional standardization of prostate multiparametric MRI performance and reporting: is there a role for a director of prostate imaging?

J Abreu-Gomez, W Shabana… - American Journal of …, 2019 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to assess prostate multiparametric MRI (mpMRI)
before and after intervention by a director of prostate imaging. MATERIALS AND METHODS …